dostęp płatny
Powikłania neuropsychiatryczne związane z COVID-19 — przegląd kliniczny
- Uniwersytet Medyczny we Wrocławiu
- Mazowieckie Specjalistyczne Centrum Zdrowia im. Prof. Jana Mazurkiewicza, Pruszków, Polska
- Klinika Psychiatryczna Wydział Nauki o Zdrowiu Warszawski Uniwersytet Medyczny
dostęp płatny
Streszczenie
Streszczenie
Pełny tekst:
Dodaj do koszyka: 49,00 PLNSłowa kluczowe
covid-19, konsekwencje neuropsychiatryczne, mechanizm neuroinwazji
Tytuł
Powikłania neuropsychiatryczne związane z COVID-19 — przegląd kliniczny
Czasopismo
Numer
Typ artykułu
Artykuł przeglądowy
Strony
232-240
Opublikowany online
2021-07-13
Wyświetlenia strony
1711
Wyświetlenia/pobrania artykułu
3231
DOI
Rekord bibliograficzny
Psychiatria 2021;18(3):232-240.
Słowa kluczowe
covid-19
konsekwencje neuropsychiatryczne
mechanizm neuroinwazji
Autorzy
Jadwiga Mosiołek
Paweł Jakubczak
Anna Mosiołek
- WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int (24.03.2021).
- Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020; 41(12): 1100–1115.
- McAloon C, Collins Á, Hunt K, et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020; 10(8): e039652.
- Xie P, Ma W, Tang H, et al. Severe COVID-19: A review of recent progress with a look toward the future. Front Public Health. 2020; 8: 189.
- Nuzzo D, Picone P. Potential neurological effects of severe COVID-19 infection. Neurosci Res. 2020; 158: 1–5.
- Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021; 76(2): 428–455.
- Zhou Y, Chi J, Lv W, et al. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021; 37(2): e3377.
- Meo SA, Alhowikan AM, Al-Khlaiwi T, et al. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020; 24(4): 2012–2019.
- Ioannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bulletin of the World Health Organization 2021. 2021; 99: 19–33.
- Su YJ, Lai YC. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan. Travel Med Infect Dis. 2020; 36: 101625.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497–506.
- Wang D, Hu Bo, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061–1069.
- Halaji M, Farahani A, Ranjbar R, et al. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med. 2020; 28(suppl 1): 6–17.
- Zhu Z, Lian X, Su X, et al. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020; 21(1): 224.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395(10229): 1054–1062.
- Rogers J, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry. 2020; 7(7): 611–627.
- Abboud H, Abboud FZ, Kharbouch H, et al. COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg. 2020; 140: 49–53.
- Azim D, Nasim S, Kumar S, et al. Neurological consequences of 2019-nCoV infection: A comprehensive literature review. Cureus. 2020; 12(6): e8790.
- Yachou Y, El Idrissi A, Belapasov V, et al. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020; 41(10): 2657–2669.
- Baig AM, Khaleeq A, Ali U, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020; 11(7): 995–998.
- Armocida D, Palmieri M, Frati A, et al. How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy. J Clin Neurosci. 2020; 79: 231–236.
- Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020; 80(4): 401–406.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–690.
- Nalleballe K, Reddy Onteddu S, Sharma R, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020; 88: 71–74.
- Lechien JR, Chiesa-Estomba CM, Place S, et al. COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020; 288(3): 335–344.
- Liguori C, Pierantozzi M, Spanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020; 88: 11–16.
- Ye M, Ren Yi, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020; 88: 945–946.
- Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 55–58.
- Efe IE, Aydin OU, Alabulut A, et al. COVID-19-associated encephalitis mimicking glial tumor. World Neurosurg. 2020; 140: 46–48.
- Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020; 296(2): E119–E120.
- Hayashi M, Sahashi Y, Baba Y, et al. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020; 415: 116941.
- Delorme C, Paccoud O, Kas A, et al. CoCo-Neurosciences study group and COVID SMIT PSL study group. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020; 27(12): 2651–2657.
- Kishfy L, Casasola M, Banankhah P, et al. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci. 2020; 414: 116943.
- Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, et al. Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J Neurol. 2020; 267(11): 3157–3160.
- Chen T, Wu Di, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368: m1091.
- Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005; 75(2): 185–194.
- Caress JB, Castoro RJ, Simmons Z, et al. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience. Muscle Nerve. 2020; 62(4): 485–491.
- Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020; 87: 34–39.
- Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020; 95(8): e1060–e1070.
- Qi R, Chen W, Liu S, et al. Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors. medRxiv. 2020.
- Forte G, Favieri F, Tambelli R, et al. COVID-19 pandemic in the italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health. 2020; 17(11).
- Johnson SU, Ebrahimi OV, Hoffart A. PTSD symptoms among health workers and public service providers during the COVID-19 outbreak. PLoS One. 2020; 15(10): e0241032.
- González-Sanguino C, Ausín B, Castellanos MÁ, et al. Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun. 2020; 87: 172–176.
- Beach SR, Praschan NC, Hogan C, et al. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020; 65: 47–53.
- Mcloughlin BC, Miles A, Webb TE, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020; 11(5): 857–862.
- Ferrando SJ, Klepacz L, Lynch S, et al. COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020; 61(5): 551–555.
- Godeau D, Petit A, Richard I, et al. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324(6): 603–605.